Search

Your search keyword '"White, Andrew V"' showing total 19 results
Start Over Author "White, Andrew V"
19 results on '"White, Andrew V"'

1. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure

Author

Hoy, Wendy E., White, Andrew V., Tipiloura, Bernard, Singh, Gurmeet R., Sharma, Suresh, Bloomfield, Hilary, Swanson, Cheryl E., Dowling, Alison, and McCredie, David A.

Published
2016
Full Text
View/download PDF

4. Zinc and vitamin A supplementation in indigenous Australian children hospitalized with lower respiratory tract infection: A randomized controlled trial

Author

Chang, Anne B., Boyce, Naomi C., White, Andrew V., Torzillo, Paul J., Stewart, Peter M., Wheaton, Gavin R., Purdie, David M., Wakerman, John, and Valery, Particia C.

Subjects
Australian aborigines -- Health aspects, Zinc in the body -- Nutritional aspects, Vitamin A -- Nutritional aspects, Dietary supplements -- Health aspects, Respiratory tract infections -- Care and treatment, Children -- Health aspects, Health
Abstract

A study was conducted to evaluate the efficacy of supplementation of zinc and vitamin A in indigenous children suffering from lower respiratory tract infection (ALRI). It was concluded that this study does not support the use of zinc and vitamin A in the management of ALRI.

Published
2006

6. Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life

Author

White, Andrew V., Hoy, Wendy E., and McCredie, David A.

Subjects
Kidney diseases -- Research, Streptococcal infections -- Research, Glomerulonephritis -- Research, Australian aborigines -- Diseases, Health
Abstract

By studying a group of Australian Aboriginal children who had been diagnosed with post-streptococcal glomerulonephritis (PSGN), it was found that this disease is a risk factor for albuminuria and haematuria later on in life. Tests were performed by measuring the ratio of albumin to creatinine in the urnie, which is a sensitive early marker of kidney damage.

Published
2001

8. Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol

Author

Sloots Theo P, Maclennan Carolyn, White Andrew V, Grimwood Keith, Chang Anne B, Sive Alan, McCallum Gabrielle B, Mackay Ian M, and Morris Peter S

Subjects
Medicine (General), R5-920
Abstract

Abstract Background Acute lower respiratory infections are the commonest cause of morbidity and potentially preventable mortality in Indigenous infants. Infancy is also a critical time for post-natal lung growth and development. Severe or repeated lower airway injury in very young children likely increases the likelihood of chronic pulmonary disorders later in life. Globally, bronchiolitis is the most common form of acute lower respiratory infections during infancy. Compared with non-Indigenous Australian infants, Indigenous infants have greater bacterial density in their upper airways and more severe bronchiolitis episodes. Our study tests the hypothesis that the anti-microbial and anti-inflammatory properties of azithromycin, improve the clinical outcomes of Indigenous Australian infants hospitalised with bronchiolitis. Methods We are conducting a dual centre, randomised, double-blind, placebo-controlled, parallel group trial in northern Australia. Indigenous infants (aged ≤ 24-months, expected number = 200) admitted to one of two regional hospitals (Darwin, Northern Territory and Townsville, Queensland) with a clinical diagnosis of bronchiolitis and fulfilling inclusion criteria are randomised (allocation concealed) to either azithromycin (30 mg/kg/dose) or placebo administered once weekly for three doses. Clinical data are recorded twice daily and nasopharyngeal swab are collected at enrolment and at the time of discharge from hospital. Primary outcomes are 'length of oxygen requirement' and 'duration of stay,' the latter based upon being judged as 'ready for respiratory discharge'. The main secondary outcome is readmission for a respiratory illness within 6-months of leaving hospital. Descriptive virological and bacteriological (including development of antibiotic resistance) data from nasopharyngeal samples will also be reported. Discussion Two published studies, both involving different patient populations and settings, as well as different macrolide antibiotics and treatment duration, have produced conflicting results. Our randomised, placebo-controlled trial of azithromycin in Indigenous infants hospitalised with bronchiolitis is designed to determine whether it can reduce short-term (and potentially long-term) morbidity from respiratory illness in Australian Indigenous infants who are at high risk of developing chronic respiratory illness. If azithromycin is efficacious in reducing the morbidly of Indigenous infants hospitalised with bronchiolitis, the intervention would lead to improved short term (and possibly long term) health benefits. Trial registration Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12610000326099

Published
2011
Full Text
View/download PDF

10. Zinc and vitamin A supplementation in Australian indigenous children with acute diarrhoea: A randomized controlled trial

Author

Valery, Patricia C., Torzillo, Paul J., Chang, Anne B., Boyce, Naomi C., Wakerman, John, White, Andrew V., Purdie, David M., Stewart, Peter A., and Wheaton, Gavin R.

Subjects
Diarrhea in children -- Care and treatment, Vitamin A -- Nutritional aspects, Zinc in the body -- Nutritional aspects, Health
Abstract

The role of zinc and vitamin A supplementation in the recovery of indigenous children hospitalized for acute diarrhoea is evaluated. The results revealed that vitamin A and zinc supplementation might not be indicated for in-hospital management of acute diarrhoeal disease in Aboriginal children living in remote areas.

Published
2005

11. Three-Weekly Doses of Azithromycin for Indigenous Infants Hospitalized with Bronchiolitis: A Multicentre, Randomized, Placebo-Controlled Trial

Author

McCallum, Gabrielle B., primary, Morris, Peter S., additional, Grimwood, Keith, additional, Maclennan, Carolyn, additional, White, Andrew V., additional, Chatfield, Mark D., additional, Sloots, Theo P., additional, Mackay, Ian M., additional, Smith-Vaughan, Heidi, additional, McKay, Clare C., additional, Versteegh, Lesley A., additional, Jacobsen, Nerida, additional, Mobberley, Charmaine, additional, Byrnes, Catherine A., additional, and Chang, Anne B., additional

Published
2015
Full Text
View/download PDF

12. The multideterminant model of renal disease in a remote Australian Aboriginal population in the context of early life risk factors: lower birth weight, childhood post-streptococcal glomerulonephritis, and current body mass index influence levels of albumi

Author

Hoy, Wendy E., primary, White, Andrew V., additional, Tipiloura, Bernard, additional, Singh, Gurmeet, additional, Sharma, Suresh K., additional, Bloomfield, Hilary, additional, Swanson, Cheryl E., additional, Dowling, Alison, additional, and McCredie, David A., additional

Published
2015
Full Text
View/download PDF

13. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure

Author

Hoy, Wendy E., primary, White, Andrew V., additional, Tipiloura, Bernard, additional, Singh, Gurmeet R., additional, Sharma, Suresh, additional, Bloomfield, Hilary, additional, Swanson, Cheryl E., additional, Dowling, Alison, additional, and McCredie, David A., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results